According to reports, 80% of the critical clinical trials in life sciences and pharma organizations get delayed due to recruitment issues as patients look to participate in the study that can integrate into their daily lives with minimal effort. The advancement in the technology sector can bring innovation to enhance the patient experience in clinical trials.
Pharmaceutical marketers must reconsider their current trial methods through digital transformation, i.e., bringing trials to the patient using technology. This approach can help patients interact more and adhere to the care plan. It can also reduce the costs borne by the organizations in different stages of a trial.
The white paper elaborates on how the life sciences and healthcare industry can enhance patients’ journeys in clinical trials and, in turn, provide benefits like
- Cost efficiency
- An increase in patient participation
- Reduction in patient dropouts
